Collegium Pharmaceutical, Inc. Common Stock (COLL) is a publicly traded Healthcare sector company. As of May 21, 2026, COLL trades at $34.21 with a market cap of $1.09B and a P/E ratio of 14.45. COLL moved +1.81% today. Year to date, COLL is -25.09%; over the trailing twelve months it is +14.22%. Its 52-week range spans $23.23 to $50.79. Analyst consensus is strong buy with an average price target of $53.40. Rallies surfaces COLL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Collegium Pharmaceutical, Inc. Common Stock (COLL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. COLL moved +1.81% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $34.21 |
| Market Cap | $1.09B |
| P/E Ratio | 14.45 |
| EPS | $2.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.79 |
| 52-Week Low | $23.23 |
| Volume | 231.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $796.33M |
| Net Income | $74.95M |
| Gross Margin | 60.68% |
6 analysts cover COLL: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $53.40.